[Only registered and activated users can see links. Click Here To Register...] Results from the phase I investigation indicated that, at the selected dose 420 mg day, greater than 95 of BTK is occupied and inactivated by ibrutinib
نمایش نسخه قابل چاپ
[Only registered and activated users can see links. Click Here To Register...] Results from the phase I investigation indicated that, at the selected dose 420 mg day, greater than 95 of BTK is occupied and inactivated by ibrutinib